Tethys picks up $25M for diabetes diagnostic
Tethys Bioscience, maker of a diagnostic test that indicates which patients are at the highest risk for developing Type 2 diabetes, has raised $25 million in a fourth round of funding. Based in Emeryville, Calif., the company is backed by Aeris Capital, Wasatch Advisors, Intel Capital, Kleiner Perkins Caufield & Byers and Mohr Davidow Ventures. It has raised about $80 million to date.
Adamas scores $40M, Navy funds to tackle the flu
Adamas Pharmaceuticals, one of Mohr Davidow Ventures‘ key life science investments, has raised $40 million in a fourth round of funding to develop antiviral treatments for the flu virus. Based in Emeryville, Calif., the company also just signed a research agreement with the U.S. Navy to accelerate drug development in this area.
The funding is significant not only due to its size in a lean time for life science companies, but also because the flu has… Continue Reading
Livescribe raises $7.5M more for Pulse smartpen
Livescribe, the maker of the Pulse smartpen that creates an audio recording linked to your handwritten notes, has raised $7.5 million in a second round of funding.
The Oakland, Calif. company has been making funding announcements throughout the past year, but all the previous news was about additions to Livescribe’s first round from the initial investors. In fact, Livescribe announced $10.175 million in new first-round funding as recently as February (the new announcement adjusts that number… Continue Reading
DecisionView lands financing to optimize clinical trials
DecisionView, developer of software applications that streamline the clinical trials process for biotech and pharmaceutical companies, announced today that it closed a fourth-round of funding earmarked for product development — including additional work on its top offering, the StudyOptimizer.
The San Francisco-based company claims that the StudyOptimizer is the first web-based application for clinical trial enrollment, a cumbersome process that can sometimes stall drugs and devices for months, if not indefinitely. In facilitating the recruitment of… Continue Reading
Mobile ad company Smaato raises $3.5M
Mobile ad technology company Smaato announced Friday that it has completed a $3.5-million first round of financing.
In a competitive field, the San Mateo-based company says it stands out with its SOMA (short for Smaato Open Mobile Advertising) platform, which delivers targeted, in-application ads. The company has teamed up with ad-sales networks including Adconion Media Group and Third Screen Media.
According to Smaato, the new funding includes angel investors from international media, advertising, mobile technology and finance…. Continue Reading